Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P-321 in Dry Eye Disease
NCT02242032Phase 1Completed
- Sponsor
- Parion Sciences
- Start
- Jul 2014
- Primary completion
- Mar 2015
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of P-321 Ophthalmic Solution placebo in dry eye disease (DED) (2 arms), sponsored by Parion Sciences. Primary endpoints: Number of subjects with adverse events, Changes from baseline in visual acuity at 28 days and 4 more. Started Jul 2014; status: completed.
02
Drugs
P-321 Ophthalmic Solution placebo
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT02242032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242032.